Toxicology of platinum and platinum-group metals
Roshchin, A.V.; Veselov, V.G.; Panova, A.I.
Gigiena Truda i Professional'nye Zabolevaniya (9): 4-9
1979
ISSN/ISBN: 0016-9919 PMID: 535753 Document Number: 139371
Document emailed within 1 workday
Related Documents
Endo, K.; Akamatsu, K.; Matsumoto, T.; Morikawa, K.; Koizumi, M.; Mitsui, H.; Koizumi, K. 1992: Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice Anticancer Research 12(1): 49-58Ota, K.; Oguma, T.; Shimamura, K. 1994: Pharmacokinetics of platinum in cancer patients following intravenous infusion of cis-diammine(glycolato)platinum, 254-S Anticancer Research 14(3b): 1383-1387
Winograd, B.; Vermorken, J.B.; ten Bokkel Huinink, W.W.; Simonetti, G.; Gall, H.E.; Knobf, M.K.; van der Vijgh, W.J.; McVie, J.G.; Pinedo, H.M. 1986: Phase i study of ethylenediamine platinum(II) malonate (NSC 146 068), a second generation platinum analogue Cancer Research 46(4 Part 2): 2148-2151
Saegusa, Y.; Eriguchi, M.; Kidani, Y.; Matsuzawa, A.; Takeda, Y. 2001: Antitumor effects of a new lipophilic platinum compound, trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), in mice Anticancer Research 21(1a): 245-252
Linasmita, V.; Wilailak, S.; Srisupundit, S.; Tangtrakul, S.; Bullangpoti, S.; Israngura, N. 1998: Epithelial ovarian cancer treated by platinum or platinum analogue with cyclophosphamide: experience in Ramathibodi Hospital Journal of the Medical Association of Thailand 81(1): 10-16
Siddik, Z.H.; Thai, G.; Yoshida, M.; Zhang, Y.P.; Khokhar, A.R. 1994: Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo Anti-Cancer Drug Design 9(6): 495-509
Kelland, L.R.; Abel, G.; McKeage, M.J.; Jones, M.; Goddard, P.M.; Valenti, M.; Murrer, B.A.; Harrap, K.R. 1993: Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug Cancer Research 53(11): 2581-2586
Wachters, F.M.; Van Der Graaf, W.T.A.; Groen, H.J.M. 2004: Cardiotoxicity in advanced non-small cell lung cancer patients treated with platinum and non-platinum based combinations as first-line treatment Anticancer Research 24(3b): 2079-2083
Kanzawa, F.; Maeda, M.; Sasaki, T.; Hoshi, A.; Kuretani, K. 1982: Murine lymphoma L5178Y cells resistant to purine antagonists: differences in cross-resistance to thioguanine-platinum(II) and selenoguanine-platinum(II) Journal of the National Cancer Institute 68(2): 287-291
Sawada, M.; Ozaki, M.; Taniguchi, H.; Tateishi, R.; Mori, Y.; Mino, K. 1988: Effect of a newly developed platinum compound cis-1, 1-cyclobutane dicarboxylato-(2R)-2-methyl-1,4-butane diamine platinum (II), on human ovarian tumors transplanted into nude mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(4 Part 1): 637-641
Drewa, T.; Olszewska-Słonina, D.; Woźniak, A.; Styczyński, J.; Drewa, G.; Szłyk, E.; Lakomska, I.; Kobe, J.; Czajkowski, R.ł 2004: Influence of a novel platinum compound--cis-dichloro (dimethylsulphoxide) (1-beta-D-rybofuranosyl-1,2,4-triazolo-3-arboxyamide) platinum (II)--"Pt-rib-1"--on cell cycle and apoptosis in ClS91 and B16 mouse melanoma in vitro Acta Poloniae Pharmaceutica 61(1): 39-44
Hannemann, J.; Baumann, K. 1988: Inhibition of lactate-dehydrogenase by cisplatin and other platinum-compounds: enzyme leakage of LDH is not a suitable method to measure platinum-compound-induced kidney cell damage in vitro Research Communications in Chemical Pathology and Pharmacology 60(3): 371-379
Ross, S.A.; Carr, C.A.; Brïet, J.W.; Lowe, G. 2000: Transfer of 4'-chloro-2,2':6',2"-terpyridine platinum(II) between human serum albumin, glutathione and other thiolate ligands. a possible selective natural transport mechanism for the delivery of platinum(II) drugs to tumour cells Anti-Cancer Drug Design 15(6): 431-439
Hong, R.; Ma, F.; Shi, X.; Li, Q.; Zhang, P.; Yuan, P.; Wang, J.; Fan, Y.; Cai, R.; Li, Q.; Xu, B. 2014: Comparison of the effectiveness of platinum-based chemotherapy versus non-platinum-based chemotherapy for triple-negative breast cancer with metastases confined to the lungs Zhonghua Zhong Liu Za Zhi 36(10): 788-792
Ezcurdia, L.; Jovtis, S.L.; Mickiewicz, E.; Temperley, G.; Rondinón, M.; Blajman, C.; Cóppola, F.S.; Lewi, D.; Cazap, E.; Breier, S.; Fasce, H.; Fein, L.; Polera, J.; Triguboff, E.; Uranga, G.; Pasccón, G.; Luchina, A.M.; Martínez, C.A.; Politi, P.M.; Rubio, G.; Alvarez, A.M. 1997: Paclitaxel in platinum-resistant ovarian cancer patients. Argentine Multicenter Taxol Group Seminars in Oncology 24(5 Suppl. 15): S15
Taguchi, T.; Wakui, A.; Nabeya, K.; Kurihara, M.; Isono, K.; Kakegawa, T.; Ota, K. 1992: A phase Ii clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(4): 483-488
MacMillan, P. 1980: The platinum ladies Nursing Times 76(14): 584
Mano, T.; Takeshima, N.; Nakamura, Y.; Tomimatsu, T.; Saito, T.; Miyake, T. 1987: Treatment of gynecological cancer with cis-platinum Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(10): 2895-2899
Doz, F.; Pinkerton, R.; Pacquement, H.; Michon, J.; Quintana, E.; Bastian, G.; Chazard, M.; Pellae-Cosset, B.; Zucker, J.M. 1993: Platinum derivatives in pediatric oncology Archives Francaises de Pediatrie 50(4): 353-359
Sulkes, A.; Peretz, T.; Rizel, S.; Yahalom, Y.; Brian, S. 1986: New frontiers in cancer chemotherapy: cis-platinum Harefuah 110(2): 90-93